Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 150 of 2051 entries
View as:

Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00743431 Org: User:
Start: 02/28/05 End: 12/31/08 Due: 12/31/09

A Study of the Effect of Nemtabrutinib (MK-1026) on the Plasma Levels of Digoxin in Healthy Participants (MK-1026-012)

Phase: N/A Priority: Normal
NCT ID: NCT06625827 Org: User:
Start: 11/07/23 End: 01/22/24 Due: 01/22/25

A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)

Phase: N/A Priority: Normal
NCT ID: NCT01276847 Org: User:
Start: 03/31/11 End: 12/31/11 Due: 12/31/12

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Phase: N/A Priority: Normal
NCT ID: NCT04220866 Org: User:
Start: 03/04/20 End: 09/30/22 Due: 09/30/23

A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)

Phase: N/A Priority: Normal
NCT ID: NCT01734239 Org: User:
Start: 06/03/13 End: 10/22/13 Due: 10/22/14

MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)

Phase: N/A Priority: Normal
NCT ID: NCT00768170 Org: User:
Start: 09/30/08 End: 05/31/09 Due: 05/31/10

Activity Tracking Study in Healthy Volunteers (MK-0000-419)

Phase: N/A Priority: Normal
NCT ID: NCT06833879 Org: User:
Start: 05/12/22 End: 06/16/22 Due: 06/16/23

Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00120861 Org: User:
Start: 01/31/05 End: - Due: -

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)

Phase: N/A Priority: Normal
NCT ID: NCT01362530 Org: User:
Start: 09/13/11 End: 08/16/13 Due: 08/16/14

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Phase: N/A Priority: Normal
NCT ID: NCT03740165 Org: User:
Start: 12/18/18 End: 05/29/26 Due: 05/29/27

Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)

Phase: N/A Priority: Normal
NCT ID: NCT02062502 Org: User:
Start: 03/07/14 End: 10/13/15 Due: 10/13/16

The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)

Phase: N/A Priority: Normal
NCT ID: NCT03108924 Org: User:
Start: 04/14/17 End: 09/13/17 Due: 09/13/18

Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00850616 Org: User:
Start: 04/30/05 End: 03/31/11 Due: 03/31/12

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Phase: N/A Priority: Normal
NCT ID: NCT05602727 Org: User:
Start: 12/02/22 End: 09/27/23 Due: 09/27/24

Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

Phase: N/A Priority: Normal
NCT ID: NCT00709228 Org: User:
Start: 05/31/06 End: 11/30/08 Due: 11/30/09

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Phase: N/A Priority: Normal
NCT ID: NCT01506271 Org: User:
Start: 06/01/12 End: 08/12/14 Due: 08/12/15

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Phase: N/A Priority: Normal
NCT ID: NCT01945281 Org: User:
Start: 01/15/14 End: 02/28/18 Due: 02/28/19

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00060645 Org: User:
Start: 05/31/03 End: 02/28/09 Due: 02/28/10

Dyslipidemia in Type 2 Diabetes (0767-034)

Phase: N/A Priority: Normal
NCT ID: NCT00547274 Org: User:
Start: 07/31/03 End: 11/30/03 Due: 11/30/04

Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699)

Phase: N/A Priority: Normal
NCT ID: NCT00724932 Org: User:
Start: 07/16/08 End: 05/03/09 Due: 05/03/10

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00005118 Org: User:
Start: - End: - Due: -

A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)

Phase: N/A Priority: Normal
NCT ID: NCT00988884 Org: User:
Start: 10/21/09 End: 02/22/11 Due: 02/22/12

Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

Phase: N/A Priority: Normal
NCT ID: NCT00871910 Org: User:
Start: 10/11/06 End: 02/22/10 Due: 02/22/11

A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

Phase: N/A Priority: Normal
NCT ID: NCT00758836 Org: User:
Start: 12/03/08 End: 08/24/09 Due: 08/24/10

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Phase: N/A Priority: Normal
NCT ID: NCT00960063 Org: User:
Start: 11/11/09 End: 12/22/10 Due: 12/22/11